These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33297930)

  • 21. MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
    Chen C; Pan Y; Bai L; Chen H; Duan Z; Si Q; Zhu R; Chuang TH; Luo Y
    Breast Cancer Res; 2021 Jan; 23(1):12. PubMed ID: 33494814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Peng X; Yan B; Shen Y
    Breast Cancer; 2018 Nov; 25(6):742-752. PubMed ID: 29951881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angelica sinensis polysaccharide suppresses the Wnt/β-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p/PCDH10 axis.
    Cai Y; Wang Y; Su W; Zhou X; Lu C
    Biochem Pharmacol; 2024 Jul; 225():116295. PubMed ID: 38762145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
    Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
    J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
    Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
    Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
    Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K
    Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
    Yue X; Wu WY; Dong M; Guo M
    Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-491 suppresses migration and invasion via directly targeting TPX2 in breast cancer.
    Tan GZ; Li M; Tan X; Shi ML; Mou K
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9996-10004. PubMed ID: 31799669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
    Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-542-3p targets sphingosine-1-phosphate receptor 1 and regulates cell proliferation and invasion of breast cancer cells.
    Wu HX; Wang GM; Lu X; Zhang L
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):108-114. PubMed ID: 28121348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
    Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
    Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
    Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
    BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2.
    Wang H; Hu X; Yang F; Xiao H
    Oncol Res; 2021 Sep; 28(7):731-744. PubMed ID: 33419488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.